Explain how the prevalence of a health problem is measured, why obesity has risen worldwide and differs between populations, and apply the same reasoning to tobacco addiction, drug misuse and social media addiction.
Each is in the Psychology glossary, with every other term in the subject.
A pattern of compulsive use of a substance or engagement in an activity that continues despite harmful consequences, marked by craving, loss of control and often tolerance and withdrawal.
A measure of body size calculated as weight in kilograms divided by the square of height in metres, used as an indirect measure of body fat in population research.
The use of a legal or illegal drug in a way that harms the user or others, or that is not medically intended, such as taking a prescription drug in larger doses than prescribed.
The number of new cases of a condition that develop in a population during a stated period, usually expressed as a rate per 100 or per 1,000 people per year.
The shift in a population’s diet and activity from traditional foods and active work towards processed, energy-dense foods, sugary drinks and sedentary lives, which accompanies economic development and urbanisation.
An excess of body fat that presents a risk to health; in adults it is usually operationalised as a body mass index of 30 kg/m² or more.
The sum of the surroundings, opportunities and conditions of life, such as food supply, marketing, transport and urban design, that promote weight gain in a population.
Explain the difference between prevalence and incidence, and how the prevalence of a health problem is measured.
Evaluate body mass index as an operationalisation of obesity, including its limits across populations.
Explain why the prevalence of obesity has changed over time, with reference to the nutrition transition and the obesogenic environment.
Explain why the prevalence of obesity differs between populations, including countries, migrant groups, socioeconomic groups and the sexes.
Apply the same questions to a second health problem: tobacco addiction, drug misuse or social media addiction.
Discuss how biological, cognitive and sociocultural factors interact to produce changes and differences in prevalence.
Evaluate prevalence research with reference to measurement, causality, bias and responsibility.
The prevalence of a health problem is the proportion of a population affected by it. Prevalence figures show which problems are growing, which groups carry the greatest burden and where prevention is most needed. Adult obesity, for example, has more than doubled worldwide since 1990, while smoking has fallen in most countries over the same period.
Psychologists ask two questions about these figures: why prevalence changes within a population over time, and why it differs between populations at the same time. The answers draw on all three approaches. Genes affect who is vulnerable, cognitive processes shape everyday choices about food, drugs and screens, and sociocultural factors such as norms, income and the food environment shape the situations in which those choices are made. Because no single factor explains the patterns, prevalence research is a clear example of
With a free account, Augment remembers where you stopped and what you have practiced.
A pattern of excessive, compulsive social media use that the person finds hard to control and that interferes with daily functioning, sleep, study or relationships; not an official diagnosis.
A health problem is a condition that harms physical health or well-being and is closely linked to behaviour. Obesity, drug misuse and social media addiction are all health problems in this sense. They differ from mental health disorders such as depression because they are usually defined by a health risk or a pattern of behaviour rather than by a psychiatric diagnosis, although the two often occur together.
Prevalence counts everyone who has a condition, however long they have had it. It is usually expressed as a percentage of the population. Point prevalence is the proportion affected at one moment (for example, adults with obesity in 2024), and lifetime prevalence is the proportion who have ever had the condition.
Incidence counts only new cases arising during a period, usually as a rate (new cases per 1,000 or per 100 people per year). Incidence shows how quickly a problem is spreading; prevalence shows how large it is.
The two are linked like water in a reservoir. New cases flow in at the rate of incidence, and cases flow out when people recover or die. Prevalence therefore rises when incidence rises, but it can also rise when incidence is stable and people simply live longer with the condition. Obesity is a good example, since few adults who develop it return to a healthy weight, so each year’s new cases add to the stock.
Prevalence is estimated from large, representative surveys of a population. The most trustworthy obesity surveys measure height and weight directly, as the national health surveys of the United States, England, China and many other countries do. Smoking and drug use are usually measured by self-report in household surveys, sometimes checked against biological markers such as cotinine, a substance the body produces from nicotine. Social media addiction is measured with questionnaires such as the Bergen Social Media Addiction Scale.
Researchers then pool these surveys to compare countries and decades. Groups such as the NCD Risk Factor Collaboration (NCD-RisC) and the Global Burden of Disease study combine thousands of surveys and use statistical models to fill gaps for countries and years with little data. Their estimates are the best available, but they are estimates: for countries with few surveys, part of each figure is modelled rather than measured.
Obesity is an excess of body fat that presents a risk to health. Because body fat is hard to measure in millions of people, population research uses a simple proxy, the body mass index (BMI): a person’s weight in kilograms divided by the square of their height in metres.
A person who is 1.75 m tall and weighs 95 kg has a BMI of . For adults, the World Health Organization classifies a BMI of 25 or more as overweight and 30 or more as obesity. For children and adolescents, whose BMI changes naturally with age, a child’s BMI is compared with a growth reference for children of the same age and sex.
BMI is the standard way of counting obesity in prevalence research, and its categories are defined precisely so that figures can be compared.
Adult BMI (kg/m²) | WHO category |
|---|---|
Below 18.5 | Underweight |
18.5–24.9 | Healthy weight |
25.0–29.9 | Overweight (pre-obesity) |
30.0–34.9 | Obesity class I |
35.0–39.9 | Obesity class II |
40 or more | Obesity class III |
BMI needs only scales and a measuring tape, so it can be collected cheaply in huge samples and compared across countries and decades. It is also reliable: two trained researchers measuring the same person get almost the same result. At the level of populations, higher average BMI is strongly associated with type 2 diabetes, heart disease, several cancers and early death, which gives it predictive validity as a measure of health risk.
BMI is an operationalisation of obesity, not a direct measure of body fat, and this raises several validity problems.
It does not distinguish fat from muscle. A muscular athlete can have a BMI over 30 with little body fat, while an inactive person with a “healthy” BMI can carry a high proportion of fat.
It ignores where fat is stored. Fat around the abdominal organs is more harmful than fat on the hips and thighs. Waist circumference and waist-to-height ratio capture this better.
The same BMI means different things in different populations. At a given BMI, many South and East Asian populations have more body fat and a higher risk of type 2 diabetes than European populations. A WHO expert consultation in 2004 therefore suggested lower action points for Asian populations, and Japan uses a BMI of 25 as its national threshold for obesity. Applying the same cut-off of 30 everywhere is an imposed etic measure: a category developed mainly on European-origin samples is used as if it meant the same thing in every culture.
These limits matter for prevalence. Using the cut-off of 30, Japan’s adult obesity prevalence is about 5%, one of the lowest in the world. A lower, population-specific cut-off would produce a higher figure. Neither figure is the single true prevalence, because each depends on how the construct was operationalised.
YouTubePrevalence figures also depend on how height and weight are collected. In self-report surveys, people tend to under-report their weight and over-report their height, partly because of social desirability bias. This lowers BMI and leads to underestimates of obesity. Studies that compare self-report with measured data in the same people consistently find this direction of error, which is why the most trusted international estimates use only measured data.
Adult obesity was uncommon in most of the world in 1990. Since then it has risen in almost every country, though at very different speeds. The chart shows WHO estimates for five populations: the United States and Mexico rose steeply from already high levels, the world average more than doubled, and China rose from about 1% to about 9%. Japan rose too, but slowly and from a very low level.
A change of this size in about thirty years cannot be explained by genes. The gene pool of a population changes over many generations, not within one, so a rapid rise in prevalence must come mainly from changes in the environment and in behaviour. Genes still matter, but in a different way: they help explain which individuals gain weight when the environment changes.
Adoption and twin studies show that body weight is highly heritable within a population. A well-known example is the FTO gene. Frayling et al. (2007) studied 38,759 people in 13 European-origin cohorts and found that the 16% of adults with two copies of a common FTO variant weighed about 3 kg more on average and had 1.67 times the odds of obesity of people with no copy. This is a small effect for any one person. Hundreds of such variants together make some people more likely than others to gain weight in an environment where food is plentiful.
High heritability within a population and a rapid environmental change in prevalence are not contradictory. Heritability describes how much of the variation between people in one environment is linked to genetic differences. If the whole environment shifts towards cheap, energy-dense food and less movement, the average rises for everyone, and the genetically susceptible rise most. This is a gene–environment interaction, the same reasoning as the diathesis-stress model.
Popkin, Adair and Ng (2012) described a nutrition transition that began in high-income countries and has spread rapidly to low- and middle-income countries since the 1990s. Diets shift from traditional foods based on grains, pulses and vegetables towards processed foods, edible oils, sugar-sweetened drinks and meals eaten away from home. At the same time, work moves from farms and factories to offices, and transport from walking and cycling to motor vehicles. The result is more energy taken in and less energy used.
The transition explains why obesity in countries such as China, Mexico and Brazil rose much faster than it had in Europe decades earlier: the changes in food and work that took Europe a century happened in one or two decades. It also explains why rising obesity is linked to urbanisation: city life brings supermarkets, fast food, motorised transport and desk-based work at the same time.
Swinburn et al. (2011) argued in The Lancet that the near-simultaneous rise in obesity in almost every country is driven mainly by changes in the global food system, which produces more processed, affordable and heavily marketed food than ever before. They described the result as passive overconsumption: people eat more energy than they need without deciding to, because the environment makes it easy, which is why such surroundings are called an obesogenic environment. Local factors, such as transport, urban design, income and culture, then explain why prevalence differs between places.
Most evidence for the obesogenic environment is correlational, so the causal claim is hard to test. Hall et al. (2019) provided a rare experiment. Twenty adults lived in a research clinic in the United States for four weeks and ate an ultra-processed diet for two weeks and an unprocessed diet for two weeks, in random order. The meals offered were matched for calories, sugar, fat, fibre and salt, and participants ate as much as they wanted.
On the ultra-processed diet they ate about 500 kcal a day more and gained about 0.9 kg; on the unprocessed diet they lost about 0.9 kg. Because each participant experienced both diets, the difference in intake can be attributed to the type of food rather than to differences between people.
Energy use has fallen as well. Mechanised farming and factory work, office jobs, cars, lifts and home appliances all reduce the energy people use each day, and screen-based leisure has replaced more active pastimes. These changes are hard to measure precisely across decades, but they are part of every major explanation of the obesity rise. Because the change in daily activity happened to whole populations at once, explanations based only on individual “willpower” are weak.
The environment works partly through cognition. In dual processing theory, most everyday decisions are made quickly and automatically by System 1, using habits and cues, rather than by slow, effortful System 2 reasoning. Food choices are typical System 1 decisions: people eat more from larger portions, choose what is nearest and most visible, and respond to the smell and sight of food and to advertising. When the environment is full of cues to eat energy-dense food, a mind that relies on fast, cued decisions will tend to overeat, even if the person intends to eat healthily.
Health beliefs also shape behaviour. As obesity becomes common, the perceived norm for body size shifts upwards, and people may not see their own weight as a risk. Changes in what counts as a “normal” body are partly cognitive (a schema of normal size) and partly social.
Several further factors add to the picture. Christakis and Fowler (2007) found that a person’s chance of becoming obese rose when a friend did, suggesting that norms about eating and body size spread through social networks, an idea developed under social contagion. Chronic stress raises cortisol and is linked to eating more energy-dense “comfort” food, so rising stress, for example from insecure work, may add to the trend. Shorter sleep, which has become more common, is associated with greater appetite and weight gain, although the causal direction is debated.
At any one time, prevalence varies enormously between populations. In 2024, about three quarters of adults in American Samoa and Tonga were living with obesity, compared with about one in twenty in Japan and fewer than one in thirty in Vietnam and Ethiopia. Within countries, prevalence differs by income, sex, ethnicity and whether people live in cities or in the countryside.
Some of the strongest evidence that differences between populations are mainly environmental comes from comparisons of genetically similar groups living in different conditions. Schulz et al. (2006) compared Pima Indians in Arizona, United States, with Pima Indians living a traditional farming life in the Sierra Madre mountains of Mexico. Genetic testing confirmed that the two groups were closely related. The prevalence of type 2 diabetes was 38% in the US Pima but 6.9% in the Mexican Pima, similar to that of non-Pima Mexicans in the same area, and obesity was also much lower in Mexico, where physical activity was much higher.
The study suggests that a genetic susceptibility to obesity and diabetes becomes a health problem mainly in a “Western” environment of processed food and low activity. It is also a reminder of the history behind the numbers. The high prevalence among many Indigenous peoples in North America and the Pacific followed the loss of land, traditional food systems and ways of life, so explanations that focus only on genes or individual choices leave out the social causes.
Migrants provide a natural test of environmental effects, since they carry their genes with them but change their environment. Goel et al. (2004) analysed a US national health survey of 32,374 people. Among immigrants who had lived in the United States for less than a year, the age- and sex-adjusted prevalence of obesity was 8%; among those who had lived there for at least 15 years it was 19%, approaching that of US-born adults. Height and weight were self-reported, which probably underestimates obesity, and the design is cross-sectional, so the comparison is between different immigrants rather than the same people over time.
The pattern fits acculturation: as migrants adopt the diet, transport and work patterns of the host culture, their weight moves towards its average. It also suggests that newer migrants may be protected by food habits learned through enculturation in their culture of origin, a protection that fades with time and across generations.
The very high prevalence in Pacific island nations such as Tonga, Samoa and Nauru has several interacting causes. Since the mid-20th century, imported, cheap, energy-dense foods such as white flour, sugar, tinned meat and fatty meat cuts have replaced much of the traditional diet of fish, root crops and fruit, while wage work and motor transport have reduced physical activity. Small island economies depend on imports, so the food environment changed quickly and thoroughly.
Genetic research adds a biological factor. Minster et al. (2016) studied 3,072 Samoans and found that a variant of the CREBRF gene, extremely rare in other populations but carried by about a quarter of Samoan gene copies, raised BMI by about 1.4 units per copy, a larger effect than any other common variant known. The authors suggested that it may once have helped people survive periods of food shortage by storing energy efficiently, which would be an advantage in a scarce environment and a disadvantage in an abundant one.
The geneticist James Neel proposed in 1962 that populations that had faced repeated famines might carry genes that store energy efficiently, which would cause obesity and diabetes once food became plentiful. The idea is attractive but hard to test, and critics point out that famines affected most human populations, so it does not explain why only some carry such variants. The CREBRF finding supports a thrifty effect for one variant in one population, but it does not show that thrifty genes explain obesity in general.
YouTubeCultural explanations are often given too, and they need care. Large bodies were traditionally associated with status, strength and being well cared for in Samoa. Brewis et al. (1998) asked Samoan adults in Samoa and in Auckland, New Zealand, about body size. Ideal body sizes were in fact slim, and many people were dissatisfied with their weight, but people above a healthy weight did not usually see themselves as obese, and obesity carried much less stigma than in Western societies. Culture therefore shapes how body size is perceived and judged rather than creating a simple preference for larger bodies.
Socioeconomic status (SES) shapes prevalence in different ways at different stages of a country’s development. Swinburn et al. (2011) described a predictable pattern. In low-income countries, obesity mainly affects wealthier, urban adults, especially women, because they are the first to be able to buy processed foods and to work in sedentary jobs. In high-income countries the pattern reverses: obesity is more common among people with lower incomes and less education.
Several explanations for the reversal have been proposed. Energy-dense processed food is usually cheaper per calorie than fresh fruit, vegetables and fish; poorer neighbourhoods often have more fast-food outlets and fewer safe spaces for exercise; and long or irregular working hours leave less time to cook and exercise. Chronic stress and insecurity, which are greater at low incomes, are linked to stress-related eating. Wealthier groups in high-income countries also tend to hold stronger norms favouring thinness.
Worldwide, more women than men live with obesity, and the gap is especially large in parts of the Middle East, North Africa and southern Africa. In Egypt, about 43% of adults were living with obesity in 2024, with prevalence among women far above that among men. Explanations include cultural norms that limit women’s physical activity outside the home, the effect of repeated pregnancies on weight, and, in some cultures, positive associations between a larger female body and health, fertility or prosperity. In many high-income countries the gap between men and women is small.
Japan has one of the lowest obesity prevalences of any high-income country. Its traditional diet is based on rice, fish, soy and vegetables, served in small portions, and food norms learned through enculturation discourage overeating. Public policy reinforces these norms.
Since 2005, a national law on food education (shokuiku) has promoted healthy eating in schools, where children eat a planned school lunch, and since 2008 adults aged 40–74 have had waist circumference measured at annual health checks. Other factors also contribute, including high levels of walking and public transport use. Prevalence in Japan is rising, slowly, which suggests that these protective factors reduce the effect of the global food system rather than cancel it.
The same two questions, why prevalence changes and why it differs, apply to every health problem. Addiction is a pattern of compulsive use of a substance or activity that continues despite harm, with a strong urge to use, loss of control and, for many substances, tolerance and withdrawal. Tobacco addiction is the most common substance addiction in the world, and its prevalence has changed in the opposite direction from obesity.
Worldwide, the proportion of adults who smoke or use tobacco fell from about 35% in 2000 to about 20% in 2024. The fall has been fastest in countries such as the United Kingdom, where prevalence roughly halved over the period, and in India, where it fell from over half of adults to under a quarter. In France and Indonesia, by contrast, prevalence barely changed.
Unlike the rise in obesity, the fall in smoking is largely the result of deliberate change. Since the WHO Framework Convention on Tobacco Control came into force in 2005, most countries have raised tobacco taxes, banned smoking in public places, restricted advertising and added graphic warnings to packets. These policies work through psychological mechanisms: higher prices change the rewards of smoking, smoke-free laws remove cues and opportunities, and the gradual denormalisation of smoking changes the social norm, so that smoking becomes less acceptable and fewer young people start.
Differences in policy help explain differences between countries. Indonesia is one of the few countries that has not joined the Framework Convention, tobacco advertising has been widespread, and cigarettes are cheap and heavily marketed. Norms matter as well: in France, smoking remained part of everyday social life for both sexes for longer than in the United Kingdom.
The largest differences in tobacco use are between men and women. In Indonesia, Egypt and China, between about 45% and 60% of men use tobacco but fewer than 3% of women do. In France, the United Kingdom and the United States the gap is small. Genetic or biological differences between the sexes cannot explain a gap that is enormous in one country and almost absent in another.
The pattern fits a sociocultural explanation. Where smoking is part of male social life, such as offering cigarettes as a sign of friendship and hospitality, men learn it through social learning theory and conformity to male peer norms, while smoking by women is disapproved of. In Western Europe and North America, smoking by women rose during the 20th century as norms about women’s behaviour changed and tobacco companies marketed cigarettes to women, which is why the gap there is now small. Gender norms learned through enculturation therefore shape who is exposed to the health problem in the first place.
Drug misuse is the use of a drug in a way that is harmful or not intended, including taking prescription drugs in higher doses or for longer than prescribed. Changes in its prevalence can be very rapid. In the United States, deaths from opioid overdose rose in three waves: first from prescription painkillers from the late 1990s, then from heroin from about 2010, and then from illegally made synthetic opioids such as fentanyl from about 2013.
The first wave is a clear case of an environmental change in prevalence. From the late 1990s, new long-acting opioid painkillers were heavily marketed to doctors with claims that the risk of addiction was low, and prescribing rose sharply. More people were exposed to an addictive drug, so more developed opioid addiction. When prescribing was later restricted, many people who were already addicted turned to cheaper illegal heroin and fentanyl. Differences within the country followed the same logic: areas with higher prescribing rates and fewer jobs were hit hardest. The case shows that the behaviour of doctors, companies and regulators can change prevalence as much as the behaviour of users.
Social media addiction is compulsive, uncontrolled use of social media that interferes with daily life, with features similar to substance addiction such as craving, mood change and withdrawal-like distress when use is stopped. It is not an official diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, so researchers define and measure it with questionnaires such as the Bergen Social Media Addiction Scale.
The change over time is driven by the spread of smartphones since about 2010 and the design of platforms that reward frequent checking with likes, notifications and endless feeds. In a 2024 Pew Research Center survey of US teenagers, nearly half said they were online almost constantly, about twice the proportion a decade earlier. Being online almost constantly is not the same as being addicted, but it shows how quickly exposure has changed.
Differences between populations are harder to interpret. Cheng et al. (2021) combined 63 samples with 34,798 respondents from 32 nations in a meta-analysis. The pooled prevalence depended heavily on the classification used: about 5% with the strictest criteria, about 13% with a cut-off for severe symptoms and about 25% with a cut-off for moderate symptoms. Prevalence in collectivist nations (31%) was about twice that in individualist nations (14%). The authors suggested that in collectivist cultures, staying in constant contact with one’s group may feel more necessary, but the difference may also reflect how questionnaire items are understood across cultures.
The NCD Risk Factor Collaboration (NCD-RisC), a worldwide network of health researchers that works with the World Health Organization, aimed to estimate how the prevalence of underweight and obesity had changed in every country between 1990 and 2022, for adults and for school-aged children and adolescents, using measured rather than self-reported data.
The researchers pooled 3,663 population-based studies with 222 million participants from 200 countries and territories. A study was included only if it had measured height and weight in a sample representative of a national, regional or community population; self-reported data were excluded because they underestimate weight. Adults were defined as people aged 20 and over, and obesity as a BMI of 30 or more. For ages 5–19, obesity was defined as a BMI more than two standard deviations above the median of the WHO growth reference.
Because data were sparse for some countries and years, the researchers used a Bayesian statistical model that estimated prevalence for every country and year by borrowing information from data in the same country at other times and from similar countries. Figures were age-standardised, meaning they were adjusted so that countries with older and younger populations could be compared fairly.
In 2022, about 878 million adults (504 million women and 374 million men) and 159 million children and adolescents aged 5–19 were living with obesity: more than a billion people. Between 1990 and 2022, age-standardised adult obesity prevalence more than doubled in women, from 8.8% to 18.5%, and almost tripled in men, from 4.8% to 14.0%.
The rise was close to universal. The combined prevalence of underweight and obesity rose in about four out of five countries for women and in about seven out of ten for men, and in almost all of them the increase was driven by rising obesity. The highest levels were in island nations in Polynesia, Micronesia and the Caribbean and in countries in the Middle East and North Africa. In a few countries, mostly in South Asia and parts of Africa, underweight remained a larger problem than obesity, so some populations face both problems at once.
Sources: NCD Risk Factor Collaboration (2024). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. _The Lancet, 403(10431), 1027–1050._
Obesity has become the dominant form of malnutrition in most of the world. Its rise across countries with very different genes and cultures, over a single generation, points to shared environmental drivers, especially changes in the food system and in physical activity. The persistence of underweight in some places alongside rising obesity shows that the nutrition transition is incomplete and uneven.
The study’s main strength is its measurement. Using only measured height and weight avoids the systematic underestimate of self-report, and the very large number of studies gives precise estimates for most countries. But BMI is an indirect operationalisation of body fat, and a single cut-off of 30 may underestimate health risk in Asian populations, so comparisons between regions are not fully like for like. For countries with few surveys, prevalence is partly modelled rather than observed, so those figures carry wide uncertainty intervals.
The data describe changes and differences in prevalence; they do not test their causes. The researchers’ explanations, such as changes in the food system, are inferred by linking trends to other data, which is open to the ecological fallacy: a pattern found across countries does not show that the same factor explains weight gain in each individual. Experiments such as Hall et al. (2019) and natural comparisons such as the Pima study are needed to support causal claims.
Large prevalence studies influence global policy, which raises questions of responsibility. Presenting obesity as a problem of whole populations directs attention to food systems and policy rather than blaming individuals, which may reduce weight stigma. At the same time, labelling more than a billion people with a condition defined by a crude measure risks medicalising body size, and high figures for particular ethnic groups can be misused to stereotype them.
Explanations of changes and differences in prevalence rest on large datasets, natural comparisons and a few experiments. Each kind of evidence has strengths and weaknesses that can be organised through the concepts.
Concept | How it applies to prevalence research |
|---|---|
Measurement | Prevalence depends on how a problem is operationalised: BMI cut-offs, measured or self-reported weight, and the questionnaire cut-off for social media addiction all change the figure. |
Causality | Most evidence is correlational or ecological (countries compared), so third variables and the ecological fallacy limit causal claims; experiments such as Hall et al. (2019) are rare. |
Bias | Self-report underestimates weight and drug use (social desirability); samples may miss hard-to-reach groups such as homeless people or undocumented migrants; Western cut-offs may misclassify other populations. |
Perspective | Biological, cognitive and sociocultural explanations each capture part of the picture; single-factor explanations are reductionist. |
Change | Rapid changes in prevalence show that health problems respond to the environment, so they can also be reduced; falling smoking rates show deliberate change is possible. |
Responsibility | How prevalence is reported affects stigma, blame and policy, especially for groups with high prevalence. |
Every prevalence figure depends on decisions about measurement. For obesity, the choice between measured and self-reported weight, the BMI cut-off and the age range all change the result. For smoking, surveys may count daily smokers only or include occasional smokers and users of smokeless tobacco. For social media addiction, the cut-off on a questionnaire can change the estimate fivefold. Comparisons of prevalence over time or between countries are only valid when measurement is consistent, which is why pooled datasets that harmonise definitions, such as NCD-RisC, are so valuable. Triangulation, such as checking self-reported smoking against cotinine levels, increases confidence in the figures.
Most explanations of prevalence come from correlational research: obesity rises in countries where processed food sales rise, or is higher in poorer groups.
Such correlations cannot rule out third variables; income, for example, is linked to diet, activity, stress and education at once. Natural comparisons give stronger evidence. The Pima study and the migrant study by Goel et al. (2004) hold genes roughly constant and vary the environment, which supports an environmental cause, although the groups also differ in other ways. Randomised experiments such as Hall et al. (2019) provide the clearest causal evidence, but only for short periods and small samples in artificial settings.
Causality in this field also involves interaction. Genes such as FTO and CREBRF raise risk mainly in obesogenic environments; poverty affects weight through food prices, stress and time together. Explanations that name a single cause, whether “genes”, “willpower” or “fast food”, are reductionist and miss these interactions.
Sampling bias can distort prevalence. Household surveys miss people in institutions, homeless people and some migrants, groups that may have higher rates of drug misuse in particular. Social desirability bias lowers self-reported weight, drinking and drug use. Cultural bias enters through categories developed mainly in Western populations: the BMI cut-off of 30, and questionnaires for social media addiction written in one culture and translated into others, may not mean the same thing everywhere.
Prevalence figures shape how the public sees groups with high rates of a health problem. Reports of high obesity among Pacific Islanders or Indigenous peoples, or of high drug misuse in poorer areas, can reinforce stereotypes if they are presented without the historical, economic and environmental causes. Researchers and health agencies therefore have a responsibility to report prevalence in ways that avoid blaming individuals, to involve affected communities in interpreting the data, and to communicate uncertainty, especially where figures are modelled.
Prevalence is the proportion of a population with a condition at a given time; incidence is the rate of new cases. Prevalence rises when more cases arise or fewer leave.
Obesity is usually operationalised as a BMI of 30 or more. BMI is reliable and cheap but does not measure fat directly, and a single cut-off may misclassify some populations.
NCD-RisC (2024) found that global adult obesity more than doubled between 1990 and 2022. A change this fast is environmental: the nutrition transition, the obesogenic environment and less physical activity.
Genes such as FTO and CREBRF explain who is most vulnerable within an environment; their effects depend on the environment (gene–environment interaction).
Differences between populations reflect environment (the Pima, migrants), culture (food norms, body ideals, gender roles), socioeconomic status and genetic susceptibility, acting together.
Tobacco use has fallen worldwide through policy and changing norms, while gender norms create large differences between men and women in some countries.
Drug misuse (the US opioid crisis) and social media addiction show how prescribing, marketing, technology and measurement affect prevalence.
Prevalence research is evaluated through measurement, causality (mostly correlational and ecological data), bias and responsibility (avoiding stigma and blame).
I can explain the difference between prevalence and incidence and calculate a simple prevalence figure.
I can evaluate BMI as a measure of obesity, including its limits across populations.
I can explain at least two factors behind the global rise in obesity, with evidence.
I can explain why obesity prevalence differs between countries, migrant groups, income groups and the sexes.
I can apply the same questions to tobacco addiction, drug misuse or social media addiction.
I can discuss how biological, cognitive and sociocultural factors interact in prevalence.
I can describe and evaluate the NCD-RisC (2024) study.
I can evaluate prevalence research with reference to measurement, causality, bias and responsibility.